Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: Long-term analysis of a phase II study

Journal of Neuro-Oncology

Volumn 97, Issue 1, 2010, Pages 95-100

  Balducci, Mario ^a   D'Agostino, Giuseppe Roberto ^a   Manfrida, Stefania ^a   De Renzi, Filippo ^a   Colicchio, Gabriella ^a   Apicella, Giuseppina ^a   Mangiola, Annunziato ^a   Fiorentino, Alba ^a   Frascino, Vincenzo ^a   Mantini, Giovanna ^a   De Bari, Berardino ^a   Pompucci, Angelo ^a   Valentini, Vincenzo ^a   Anile, Carmelo ^a   Cellini, Numa ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Chemoradiation; Glioblastoma; Schedule; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLIOMA; HUMAN; LEUKOPENIA; LONG TERM CARE; MALE; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SEIZURE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 77949269569     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9997-y     Document Type: Article

References (40)

1. PY When S Kesari 2008 Malignant gliomas in adults N Engl J Med 359 492 507 10.1056/NEJMra0708126
2. AR Asthagiri N Pouratian J Sherman G Ahmed ME Shaffrey 2007 Advances in brain tumor surgery Neurol Clin 25 975 1003 10.1016/j.ncl.2007.07.006 17964023 (Pubitemid 47600574)
3. M Lacroix D Abi Said DR Foumey, et al. 2001 A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 190 198 10.3171/jns.2001.95.2.0190 1:STN:280: DC%2BD38%2FlsFGitA%3D%3D 11780887
4. N Laperriere L Zuraw G Cairncross 2002 Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review Radiother Oncol 64 259 273 10.1016/S0167-8140(02)00078-6 12242114 (Pubitemid 35254019)
5. Levin V, Leibel S, Gutin P (1997) Neoplasms of the central nervous system. In: DeVita V Jr, Hellman S, Rosenberg S (eds) Cancer: principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 2022-2082
6. LM DeAngelis 2001 Brain tumors N Engl J Med 344 114 123 10.1056/NEJM200101113440207 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D 11150363 (Pubitemid 32052502)
7. E Galanis J Buckner 2000 Chemotherapy for high-grade gliomas Br J Cancer 82 1371 1380 1:CAS:528:DC%2BD3cXivFGisLg%3D 10780513
8. HA Fine KBG Dear JS Loeffler PM Black GP Canellos 1993 Meta-analysis of radiation therapy with and without adjuvant chemo-therapy for malignant gliomas in adults Cancer 71 2585 2597 10.1002/1097-0142(19930415)71:8<2585::AID- CNCR2820710825>3.0.CO;2-S 1:STN:280:DyaK3s3gtFCrtQ%3D%3D 8453582
9. LA Stewart 2002 Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 1011 1018 10.1016/S0140-6736(02)08091-1 1:CAS:528: DC%2BD38XisV2htro%3D 11937180 (Pubitemid 34286538)
10. R Stupp WP Mason MJ van den Bent, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 987 996 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D 15758009 (Pubitemid 40349501)
11. Y Hirose MS Berger RO Pieper 2001 p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells Cancer Res 61 1957 1963 1:CAS:528:DC%2BD3MXit1Ogsrk%3D 11280752
12. SR Wedge JK Porteous MG Glaser K Marcus ES Newlands 1997 In vitro evaluation of temozolomide combined with X-irradiation Anticancer Drugs 8 92 97 10.1097/00001813-199701000-00013 1:CAS:528:DyaK2sXht1aks7Y%3D 9147618 (Pubitemid 27064756)
13. HS Friedman RE Mc Lendon T Kerby, et al. 1998 DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma J Clin Oncol 16 3851 3857 1:CAS:528:DyaK1MXos1Si 9850030
14. AA Brandes A Tosoni G Cavallo, et al. 2006 Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO) Br J Cancer 95 1155 1160 10.1038/sj.bjc.6603376 1:CAS:528:DC%2BD28XhtFChs73O 17024124 (Pubitemid 44658477)
15. S Wong MA Rosenthal A Dowling, et al. 2006 Phase II study of two-weekly temozolomide in patients with high-grade gliomas J Clin Neurosci 13 18 22 10.1016/j.jocn.2004.10.018 1:CAS:528:DC%2BD28XksVWksg%3D%3D 16356721 (Pubitemid 43061123)
16. JW Yates B Chalmer FP McKegney 1980 Evaluation of patients with advanced cancer using the Karnofsky Performance Status Cancer 45 2220 2224 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q 1:STN:280:DyaL3c7ns1ygtw%3D%3D 7370963 (Pubitemid 10150440)
17. WJ Curran CB Scott J Horton, et al. 1993 Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 704 710 10.1093/jnci/85.9.704 8478956
18. Radiation Therapy Oncology Group (1999) Cooperative group common toxicity criteria v 2.0. www.rtog.org/members/toxicity/tox.html
19. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437 (Pubitemid 30099779)
20. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
21. DR Cox 1972 Regression model and life tables J R Stat Soc 34 187 220
22. SB Green DP Byar MD Walker, et al. 1983 Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for treatment of malignant glioma Cancer Treat Rep 67 121 132 1:STN:280:DyaL3s7ivFWhsg%3D%3D 6337710
23. WR Shapiro SB Green PC Burger, et al. 1989 Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: Brain Tumor Cooperative Group trial 8001 J Neurosurg 71 1 9 10.3171/jns.1989.71.1.0001 1:STN:280:DyaL1M3ptlajtg%3D%3D 2661738
24. Stupp R, Hegi ME (2003) Recent developments in the management of malignant glioma. In: Perry MC (ed) ASCO 2003 educational book. American Society of Clinical Oncology, Alexandria, pp 779-788
25. WR Shapiro 1992 Chemotherapy of malignant gliomas: studies of the BTCG Rev Neurol 148 428 434 1:STN:280:DyaK3s%2FnvFCruw%3D%3D 1448662
26. SA Grossman A O'Neill M Grunnet, et al. 2003 Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394 J Clin Oncol 21 1485 1491 10.1200/JCO.2003.10.035 1:CAS:528:DC%2BD2cXptlCksL4%3D 12697871 (Pubitemid 46594100)
27. M Deutsch SB Green TA Strike, et al. 1989 Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma Int J Radiat Oncol Biol Phys 16 1389 1396 1:STN:280:DyaL1M3lsVKmsQ%3D%3D 2542193
28. G Lanzetta C Campanella A Rozzi, et al. 2003 Temozolomide in radio-chemotherapy combined treatment for newly diagnosed glioblastoma multiforme: phase II clinical trial Anticancer Res 23 5159 5164 1:CAS:528:DC%2BD2cXhvVWitL8%3D 14981983
29. S Chibbaro L Benvenuti A Caprio, et al. 2004 Temozolomide as first-line agent in treating high-grade gliomas: phase II study J Neurooncol 67 77 81 10.1023/B:NEON.0000021728.36747.93 1:STN:280:DC%2BD2c7nsl2jtQ%3D%3D 15072451 (Pubitemid 38418252)
30. M Kocher S Kunze HT Eich R Semrau RP Müller 2005 Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma Strahlenther Onkol 181 157 163 10.1007/s00066-005-1314-x 15756519
31. V Valentini C Coco N Cellini, et al. 1999 Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity tumor response, sphincter preservation Int J Radiat Oncol Biol Phys 45 1175 1184 10.1016/S0360-3016(99)00301-6 1:CAS:528:DyaK1MXnvFeltL4%3D 10613310
32. S Mancuso D Smaniotto PL Benedetti-Panici, et al. 2000 Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma Gynecol Oncol 78 324 328 10.1006/gyno.2000.5862 1:STN:280:DC%2BD3cvlsl2ksQ%3D%3D 10985888 (Pubitemid 30688740)
33. ND Nigro HG Seydel B Considine, et al. 1983 Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal Cancer 51 1826 1829 10.1002/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3. 0.CO;2-L 1:STN:280:DyaL3s7lsFSmsA%3D%3D 6831348
34. G D'Agostino M Balducci C Anile, et al. 2007 An analysis of two different schedules of radiochemotherapy with concomitant temozolomide in high grade gliomas Proc Am Soc Clin Oncol 25 A2035
35. SE Combs J Wagner M Bischof, et al. 2008 Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients Int J Radiat Oncol Biol Phys 70 987 992 17967509
36. SE Combs J Wagner M Bischof, et al. 2008 Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens Int J Radiat Oncol Biol Phys 71 999 1005 1:CAS:528:DC%2BD1cXnsFGhtrw%3D 18258384
37. M Kocher P Frommolt SK Borberg, et al. 2008 Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma Strahlenther Onkol 184 572 579 10.1007/s00066-008-1897-0 19016015
38. T Sridhar A Gore I Boiangiu, et al. 2009 Concomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: a retrospective study Clin Oncol (R Coll Radiol) 21 19 22 1:STN:280:DC%2BD1M%2FmtFGnsg%3D%3D
39. MM Mrugala MC Chamberlain 2008 Mechanisms of disease: temozolomide and glioblastoma-look to the future Nat Clin Pract Oncol 5 476 486 10.1038/ncponc1155 1:CAS:528:DC%2BD1cXptFSmtL8%3D 18542116
40. JB Wasserfallen S Ostermann A Pica, et al. 2004 Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death Cancer 101 2098 2105 10.1002/cncr.20619 1:CAS:528:DC%2BD2cXhtVShtb7K 15389472 (Pubitemid 39425387)